What BPC 157 sublingual searches leave out
The useful answers start with what was actually tested. Here are the questions I keep coming back to.

Does BPC-157 work under the tongue?
The sources used here don't establish a human treatment benefit from sublingual BPC-157. That isn't a finding that nothing gets through. It means the evidence doesn't answer the question.
The rat ulcer experiment compared muscle and stomach routes. The small human safety report involved delivery into a vein. Neither tested a preparation under a person's tongue. A study can be real and still be the wrong match for the claim beside it.
Does oral mean the same thing?
In everyday language, “oral” can be a bit loose. Here, swallowed means going to the stomach, while sublingual means under the tongue. Spelling it out saves a lot of confusion.
Semaglutide has approved swallowed tablets. Their evidence belongs to those products. It doesn't establish absorption for an under-the-tongue preparation, let alone for another peptide. The semaglutide page takes a closer look at the difference.
Would adding another peptide fill the gap?
The sources collected here contain no controlled human trial establishing the safety and benefit of BPC-157 combined with CJC-1295 or semaglutide. Putting two names together doesn't put their evidence together.
The CJC-1295 study measured hormones in healthy adults. The semaglutide trial measured weight change in a different group. Those results can't establish that a combination helps, or that it gets through under the tongue. A possible explanation is still something to test.
Is avoiding an injection safer?
A route can sound gentler without having a safety comparison to back it up. The research used here doesn't establish that sublingual BPC-157 is safer than an injection.
The BPC-157 review describes very limited human evidence. FDA still lists concerns about immune reactions and impurities. Those concerns aren't a measured rate of harm under the tongue. They are reasons the missing safety evidence matters. Convenience alone can't supply it.
What can I ask about a prescription?
A conversation can start with three plain questions. What exactly is the preparation? What human research used this route? What is known about possible harms, including longer-term effects?
It's also fair to ask which parts of the answer are still uncertain. A prescription records a care decision; it doesn't establish that a route works. Compounded medicines aren't FDA-approved. The route comparison gives you a way to sort the research before talking with a licensed clinician.